Cargando…

Evading p53 action during tumor development and therapy

Detalles Bibliográficos
Autor principal:	Lowe, SW
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233495/ http://dx.doi.org/10.1186/bcr1074

Ejemplares similares

p53 action in apoptosis and senescence
por: Lowe, SW, et al.
Publicado: (2000)

Drug discovery in the p53 pathway
por: Lane, DP, et al.
Publicado: (2000)

TP53 and additional pathways in therapy resistance
por: Lønning, PE
Publicado: (2005)

p53-mediated apoptosis and genomic instability syndromes
por: Spillare, EA, et al.
Publicado: (2000)

Estrogen receptor alpha-positive and negative mouse mammary tumors through somatic mutations of p53 in mammary carcinogenesis
por: Lin, S-CJ, et al.
Publicado: (2003)

Thoracoscopic surgical management of esophageal benign tumor
por: Jeon, HW, et al.
Publicado: (2013)

Apoptosis factors caspases and p53 and their impact in chronic rhinosinusitis with nasal polyposis
por: Valera, Fabiana, et al.
Publicado: (2013)

Inflammation, senescence and cancer: interweaving microRNA, inflammatory cytokines and p53 networks
por: Harris, Curtis C
Publicado: (2010)

Activation of CDK4 by Tax chemosensitizes p53-mutant cells to DNA damage
por: Semmes, O John, et al.
Publicado: (2014)

T cells are depleted in HCV-induced hepatocellular carcinoma patients: possible role of apoptosis and p53
por: Ibrahim, Sherif A, et al.
Publicado: (2006)

Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium
por: Olumi, AF, et al.
Publicado: (2000)

The actions of BAFF in B-lymphocyte maturation and its effects on the development of autoimmune disease
por: Melchers, F
Publicado: (2003)

OA01.46. Effect of LAS-02, a cancero-static compound on p53 levels in cases of different types of cancers
por: Singh, Vandana, et al.
Publicado: (2012)

Knowledge, attitude, and practice of nurses concerning immediate actions during vehicle drowning
por: Mansouri, Fatemeh, et al.
Publicado: (2022)

P011 Antifungal lock therapy
por: Koparkar, Vidyullata, et al.
Publicado: (2022)

Update on the FH01 study
por: Duffy, SW
Publicado: (2006)

Genetically altered mice and cancer research: effects of the other 99.999% of the genome and other variables upon phenotype
por: Barthold, SW
Publicado: (2003)

S5.3b Fungal spores: Initiators of colonization and infection
por: Baltussen, Tim, et al.
Publicado: (2022)

Immune complexes can dampen inflammatory signaling at the mucosal surface during protective SIV vaccination
por: Smith, AJ, et al.
Publicado: (2012)

The impact of mammographic screening on breast cancer mortality: overview of the evidence so far
por: Gabe, R, et al.
Publicado: (2004)

The role of coactivators in oestrogen action
por: Brown, M, et al.
Publicado: (2000)

Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments
por: Humbert, Marc, et al.
Publicado: (2013)

S5.3c Investigating the link between pleomorphism and virulence in Cryptococcus
por: Fernandes, Kenya, et al.
Publicado: (2022)

S5.3a Unraveling the genetic determinants of virulence in Cryptococcus neoformans
por: Jackson, Katrina, et al.
Publicado: (2022)

Tailored therapies based upon tumor subtype biology
por: Perou, CM
Publicado: (2005)

A single nucleotide polymorphism in the HDM-2 gene regulates the p53 apoptotic response and influences the age of onset of cancers in humans: the SNP 309 HDM-2 polymorphism
por: Bond, GL, et al.
Publicado: (2005)

P472 The mechanism of action of antifungal activity of Zanthoxylum armatum fruit's oil against Candida cells does not involve ROS generation
por: Pasrija, Ritu
Publicado: (2022)

IFN-α suppresses HTLV-1 expression via PKR in infected cells and renders them susceptible to AZT through p53 activation in AZT/IFN-α treatment
por: Kinpara, Shuichi, et al.
Publicado: (2014)

Dual actions of ANP on endothelial permeability
por: Chen, Wen, et al.
Publicado: (2013)

Origin of the kink of somatic action potentials
por: Teleńczuk, Maria T, et al.
Publicado: (2015)

Developing stem cell therapy for retinal dystrophies
por: Sowden, JC
Publicado: (2015)

P060 A preliminary in vitro and in vivo evaluation of the effect and action mechanism of 17-AAG combined with azoles against azole-resistant Candida spp.
por: Liu, Md Luyao
Publicado: (2022)

New mechanisms of action and signaling by TNF-α
por: Ivashkiv, Lionel B
Publicado: (2012)

Tuberculosis reactivation during novel, biologic therapy
por: Popescu, Cristina, et al.
Publicado: (2013)

Progress in the development of Reversed Chloroquine molecules as antimalarial therapy
por: Burgess, Steven J, et al.
Publicado: (2010)

Lessons from TP53 mutations in breast cancers: from carcinogen fingerprints to clinical correlates
por: Hainaut, P, et al.
Publicado: (2000)

P264 Brain phaeohyphomycosis secondary to immunosuppressant therapy due to Rhinocladiella mackenziei
por: Rai, Madhu, et al.
Publicado: (2022)

Dissemination of Cost Action FP0905 information by website
por: Migliacci, Fabio, et al.
Publicado: (2011)

Hormonal interactions during mammary gland development
por: Vonderhaar, BK
Publicado: (2003)

Development of an advanced cell therapy product indicated for the treatment of gonarthrosis
por: Vives, Joaquim, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_du235c32stbqfuq3rv9m5pvpu2